Gene therapies have the potential to be transformative, but there are hurdles to overcome for value-based contracts to become widespread.

Value-based contracts can present challenges that must be overcome to bring gene therapies to market.

Learn from industry leaders about the push to generate evidence and demonstrate healthcare provider value.